Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure.

Metformin is a widely used first-line therapy for type 2 diabetes, and studies increasingly point to its protective effects ...

Analysing the plasma from a non-diabetic heart failure cohort,4 metformin use was associated with suppression of several plasma cytokines. Conclusion This study has demonstrated that the ...

And new drugs to treat the other form of heart failure could also change the trajectory for patients with the disease. What is heart failure? There are two main kinds.

Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors.

Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor ...

The term “heart failure” refers to problems with the heart muscle’s ability to pump blood. These problems can deprive other parts of the body of sufficient oxygen and blood.

Aims Chronic heart failure (CHF) is an insulin-resistant state. The degree of insulin resistance (IR) correlates with disease severity and is associated with reduced exercise capacity. In this ...

When patients with type 2 diabetes (T2DM) and chronic heart failure (CHF) are admitted to intensive care units (ICUs), their treatment often sparks a lot of debate among doctors. The main question ...

Guo, Q., et al. (2023) Metformin Treatment is Associated with Mortality in Patients with Type 2 Diabetes and Chronic Heart Failure in the Intensive Care Unit: A Retrospective Cohort Study.